4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001650664-24-000076
CEO sold 12,191 shares at $5.50 ($66,997)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
O'Neill Gilmore Neil · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-06-04 | Sale : show line 1 in the form 10b5-1 | −12,191 | $5.50 | $66,997 | 315,279 | D |
| Open-market sales · 12,191 sh · avg $5.50 · $66,997 | ||||||
Loading xslF345X05/wk-form4_1717705020.xml…